Literature DB >> 8627440

Neutrophil and cytokine activation with neonatal extracorporeal membrane oxygenation.

J D Fortenberry1, V Bhardwaj, P Niemer, J D Cornish, J A Wright, L Bland.   

Abstract

OBJECTIVE: To determine whether extracorporeal membrane oxygenation (ECMO), like cardiopulmonary bypass, produces systemic inflammatory responses that could potentiate organ injury in infants with respiratory failure. STUDY
DESIGN: We evaluated the effects of neonatal ECMO on neutrophil surface adherence proteins, elastase release, and cytokine levels in blood samples from 15 patients before and during ECMO, and from banked blood and ECMO circuit blood before cannulation. Neutrophil elastase, tumor necrosis factor alpha, and interleukin types 1 beta, 6, and 8 were measured. Chest radiographs were evaluated by a radiologist using a lung injury score in blinded fashion.
RESULTS: Primed ECMO circuit blood, in comparison with patient pre-ECMO blood, demonstrated marked up-regulation of CD11b (mean fluorescence intensity 1660 +/- 109 vs 361 +/- 81; p < 0.001 (mean +/- SEM)), shedding of L-selectin (mean fluorescence intensity 10 +/- 2 vs 89 +/- 38; p < 0.01), and elevated elastase levels (349 +/- 76 vs 154 ng/ml +/- 38; p < 0.001), consistent with neutrophil activation. During ECMO, neutrophil CD11b levels increased but L-selectin was not significantly shed. Concentrations of circulating neutrophil elastase increase significantly during ECMO. Corrected circulating quantities of interleukin-8 also rose significantly, but the responses of tumor necrosis factor alpha and interleukin-1 beta were minimal. Radiographic lung injury scores worsened with the initiation of ECMO (median score: 6 before ECMO vs 11 in first hour of ECMO; p = 0.012), in conjunction with indicators of neutrophil activation.
CONCLUSION: Neonates with respiratory failure have activation of the inflammatory cascade. ECMO incites additional neutrophil and cytokine activation in association with early pulmonary deterioration. Routine leukodepletion of blood for circuit priming to remove activated neutrophils may be beneficial.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627440     DOI: 10.1016/s0022-3476(96)80133-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  36 in total

1.  Biocompatibility Assessment of the CentriMag-Novalung Adult ECMO Circuit in a Model of Acute Pulmonary Hypertension.

Authors:  Venkat Shankarraman; Ergin Kocyildirim; Salim E Olia; Marina V Kameneva; Ryan J Dzadony; Timothy M Maul; Marc A Simon; Hunter C Champion; William R Wagner; Christian A Bermudez
Journal:  ASAIO J       Date:  2014 Jul-Aug       Impact factor: 2.872

Review 2.  Neurocritical Care of Mechanical Circulatory Support Devices.

Authors:  Aaron Shoskes; Glenn Whitman; Sung-Min Cho
Journal:  Curr Neurol Neurosci Rep       Date:  2021-03-10       Impact factor: 5.081

3.  Changes in thyroid hormone concentrations during neonatal extracorporeal membrane oxygenation.

Authors:  L Leeuwen; A F J van Heijst; J van Rosmalen; Y B de Rijke; L W J E Beurskens; D Tibboel; E L T van den Akker; H IJsselstijn
Journal:  J Perinatol       Date:  2017-04-27       Impact factor: 2.521

4.  Extracorporeal membrane oxygenation causes loss of intestinal epithelial barrier in the newborn piglet.

Authors:  Ashish R Kurundkar; Cheryl R Killingsworth; R Britt McIlwain; Joseph G Timpa; Yolanda E Hartman; Dongning He; Rajendra K Karnatak; Mary L Neel; John P Clancy; G M Anantharamaiah; Akhil Maheshwari
Journal:  Pediatr Res       Date:  2010-08       Impact factor: 3.756

5.  Population pharmacokinetics of intravenous clonidine for sedation during paediatric extracorporeal membrane oxygenation and continuous venovenous hemofiltration.

Authors:  Niina Kleiber; Ron A A Mathôt; Maurice J Ahsman; Enno D Wildschut; Dick Tibboel; Saskia N de Wildt
Journal:  Br J Clin Pharmacol       Date:  2017-02-27       Impact factor: 4.335

6.  Surfactant Administration During Pediatric Extracorporeal Membrane Oxygenation.

Authors:  Steven L Shein; Timothy M Maul; Hong Li; Geoffrey Kurland
Journal:  ASAIO J       Date:  2015 Nov-Dec       Impact factor: 2.872

7.  Extracorporeal Membrane Oxygenation and the Kidney.

Authors:  Gianluca Villa; Nevin Katz; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2015-10-17       Impact factor: 2.041

8.  Continuous renal replacement therapy (CRRT) attenuates myocardial inflammation and mitochondrial injury induced by venovenous extracorporeal membrane oxygenation (VV ECMO) in a healthy piglet model.

Authors:  Juanhong Shen; Wenkui Yu; Qiyi Chen; Jialiang Shi; Yimin Hu; Juanjuan Zhang; Tao Gao; Fengchan Xi; Changsheng He; Jianfeng Gong; Ning Li; Jieshou Li
Journal:  Inflammation       Date:  2013-10       Impact factor: 4.092

9.  Use of a low-resistance compliant thoracic artificial lung in the pulmonary artery to pulmonary artery configuration.

Authors:  Christopher N Scipione; Rebecca E Schewe; Kelly L Koch; Andrew W Shaffer; Amit Iyengar; Keith E Cook
Journal:  J Thorac Cardiovasc Surg       Date:  2013-02-10       Impact factor: 5.209

10.  Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine.

Authors:  R Britt McILwain; Joseph G Timpa; Ashish R Kurundkar; David W Holt; David R Kelly; Yolanda E Hartman; Mary Lauren Neel; Rajendra K Karnatak; Robert L Schelonka; G M Anantharamaiah; Cheryl R Killingsworth; Akhil Maheshwari
Journal:  Lab Invest       Date:  2009-11-09       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.